A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, Denmark, where the drugmaker is currently charting a multi-year expansion to boost capacity for its blockbuster diabetes and obesity drugs Ozempic and Wegovy, among others.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,